Itumay, Rosadielima .
HRN: 23-87-90 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/15/2024
CO-AMOXICLAV 625MG (TAB)
05/15/2024
05/21/2024
PO
625
BId
Thickly Msaf
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes